Key result
Adriamycin and daunomycin produced significant cardiovascular effects including bradycardia, hypotension, and ventricular arrhythmias in hamsters and monkeys, whereas N-acetyldaunomycin caused minimal changes.
Why the study?
How do the cardiovascular effects and metabolism of daunomycin, adriamycin, and N-acetyldaunomycin compare in hamsters and monkeys?
Population
Hamsters and rhesus monkeys
Comparison
Adriamycin, Daunomycin, and N-acetyldaunomycin vs Comparison among the three compounds
Design
Preclinical
Follow-up
soon after injection
Authors
Loading...
N-acetyldaunomycin merits human testing for lower cardiotoxicity; leaves open translation and clinical utility from these animal data.
How do the cardiovascular effects and metabolism of daunomycin, adriamycin, and N-acetyldaunomycin compare in hamsters and monkeys?
The study demonstrates that N-acetyldaunomycin has significantly less acute cardiovascular toxicity than adriamycin and daunomycin, likely due to differences in its metabolism to aglycone.
Herman et al. (2008) studied this question. Adriamycin, daunomycin, and N-acetyldaunomycin was evaluated on Cardiovascular effects (bradycardia, hypotension, ventricular arrhythmias) and respiratory depression. Adriamycin and daunomycin produced significant cardiovascular effects including bradycardia, hypotension, and ventricular arrhythmias in hamsters and monkeys, whereas N-acetyldaunomycin caused minimal changes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: